Publicaciones en colaboración con investigadores/as de Hospital de la Santa Creu i Sant Pau (18)

2024

  1. Cocaine Effect Expectancies among Patients with Cocaine Use Disorder with and without Adult Attention Deficit Hyperactivity Disorder: Are There Any Relevant Differences?

    Journal of Psychoactive Drugs, Vol. 56, Núm. 1, pp. 76-87

  2. Inflammatory blood cells and ratios at remission for psychosis relapse prediction: A three-year follow-up of a cohort of first episodes of schizophrenia

    Schizophrenia Research, Vol. 267, pp. 24-31

2023

  1. Progressive loss of cortical gray matter in first episode psychosis patients with auditory hallucinations

    Schizophrenia Research

  2. The polygenic basis of relapse after a first episode of schizophrenia

    European Neuropsychopharmacology, Vol. 75, pp. 80-92

2022

  1. Different measures for auditory hallucinations in populations with psychosis. The Validation of the Spanish versions of the Auditory Vocal Hallucination Rating Scale (AVHRS) and the Positive and Useful Voices Inquiry (PUVI)

    Revista de Psiquiatria y Salud Mental, Vol. 15, Núm. 4, pp. 259-271

  2. Epigenetic clocks in relapse after a first episode of schizophrenia

    Schizophrenia, Vol. 8, Núm. 1

  3. Gene co-expression architecture in peripheral blood in a cohort of remitted first-episode schizophrenia patients

    Schizophrenia, Vol. 8, Núm. 1

  4. The role of BDNF and NGF plasma levels in first-episode schizophrenia: A longitudinal study

    European Neuropsychopharmacology, Vol. 57, pp. 105-117

2021

  1. A longitudinal study of gene expression in first-episode schizophrenia; exploring relapse mechanisms by co-expression analysis in peripheral blood

    Translational Psychiatry, Vol. 11, Núm. 1

  2. The prevention of relapses in first episodes of schizophrenia: The 2EPs Project, background, rationale and study design

    Revista de Psiquiatria y Salud Mental, Vol. 14, Núm. 3, pp. 164-176

2020

  1. Towards a common metric for assessing heroin-dependent patient satisfaction with medications: Testing methadone and buprenorphine-naloxone

    Drug and Alcohol Dependence, Vol. 212

2018

  1. A cluster-analytic profiling of heroin-dependent patients based on level, clinical adequacy, and patient-desired adjustment of buprenorphine dosage during buprenorphine-naloxone maintenance treatment in sixteen Spanish centers

    Drug and Alcohol Dependence, Vol. 187, pp. 278-284

  2. Development and validation of the scale to assess satisfaction with medications for addiction treatment – Buprenorphine-naloxone for heroin addiction (SASMAT-BUNHER)

    International Journal of Drug Policy, Vol. 58, pp. 126-134

  3. Evidence of validity and reliability of the Opiate Dosage Adequacy Scale (ODAS) in a sample of heroin addicted patients in buprenorphine/naloxone maintenance treatment

    Drug and Alcohol Dependence, Vol. 183, pp. 127-133

2017

  1. Patient perception of methadone dose adequacy in methadone maintenance treatment: The role of perceived participation in dosage decisions

    Patient Education and Counseling, Vol. 100, Núm. 5, pp. 981-986

2005

  1. Safety and effectiveness of olanzapine in monotherapy: A multivariate analysis of a naturalistic study

    Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 29, Núm. 6, pp. 944-951

  2. Safety, effectiveness, and patterns of use of olanzapine in acute schizophrenia: A multivariate analysis of a large naturalistic study in the hospital setting

    Medicina Clinica, Vol. 124, Núm. 13, pp. 481-486

2003

  1. Safety and effectiveness of olanzapine versus conventional antipsychotics in the acute treatment of first-episode schizophrenic inpatients

    Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 27, Núm. 3, pp. 473-481